Stocks · Korea
445680
KOSDAQ
Curiox Biosystems
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+11.70%
1M+22.31%
3M+40.78%
6M-32.19%
1Y+3.86%
YTD-50.46%
52W high149,200원
52W low31,650원
From 52W high-60.32%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2023 | 68억 | -106억 | -100억 | -155.5% |
| 2024 | 46억 | -134억 | -81억 | -291.6% |
| 2025 | 52억 | -123억 | -272억 | -239.0% |
| Quarterly | ||||
| 2024 4Q | 10억 | -36억 | 17억 | -379.6% |
| 2025 1Q | 9억 | -30억 | -36억 | -328.0% |
| 2025 2Q | 10억 | -40억 | -183억 | -397.5% |
| 2025 3Q | 14억 | -27억 | -30억 | -193.6% |
| 2025 4Q | 18억 | -27억 | -23억 | -143.4% |
| 2026 1Q | 13억 | -33억 | -26억 | -245.4% |
Company
Address: 서울특별시 금천구 디지털로9길 41 2층 202호, 204호 ~ 213호 (가산동, 삼성아이티해링턴타워)  
Peers in the same sector
Recent filings
- 2026-10-01[기재정정]사업보고서 (2025.12)
- 2026-10-01[기재정정]사업보고서 (2024.12)
- 2026-10-01[기재정정]사업보고서 (2023.12)
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-08-06큐리옥스바이오시스템즈 2분기 영업손실 45억원…적자 확대 연합뉴스
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.